α conotoxin imi  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Alomone Labs α conotoxin imi
    α Conotoxin Imi, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/α conotoxin imi/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    α conotoxin imi - by Bioz Stars, 2023-09
    93/100 stars

    Images

    α conotoxin imi  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Alomone Labs α conotoxin imi
    Effect of nicotinic receptor agonists and antagonists on transepithelial ion transport of mouse tracheal epithelium. (a) The α7 nicotinic ACh receptor (nAChR) antagonist α‐bungarotoxin (αBTX, 100 nmol·L −1 , n = 5, apical) or the α7 nAChR antagonist <t>α‐conotoxin</t> ImI (C. ImI, 4 μmol·L −1 , apical) or the α9α10 nAChR antagonist ACV‐1 (100 nmol·L −1 , apical) did not influence the nicotine effect (100 μmol·L −1 , apical, ΔI SC ; ns, not significant). (b) The epibatidine‐induced (α4β2, α3β2, α4β4 and α3β4 nAChR agonist) current peak (1 μmol·L −1 ) was significant compared to baseline current ( n = 5, * P < 0.05). Application of the α4β2 and α3β4 nAChR agonist A‐85380 (100 μmol·L −1 , apical, n = 5) significantly increased I SC (* P < 0.05). (c) The epibatidine effect was dose dependent ( n = 5 for each concentration). (d) In the presence of 1 μmol·L −1 of the α4β2, α3β2, α4β4 and α3β4 nAChR antagonist dihydro‐β‐erythroidine (DhβE), the nicotine effect (ΔI SC ) was similar to control conditions ( n = 5; ns, not significant), but 10 μmol·L −1 DhβE significantly reduced the nicotine‐induced current (ΔI SC , n = 5, * P < 0.05). (e) The α3β2 nAChR antagonist α‐conotoxin MII (C. MII) did not influence the nicotine effect (ΔI SC ) in a concentration of 50 nmol·L −1 ( n = 5; ns, not significant) but significantly reduced the nicotine‐induced current (ΔI SC , n = 5, * P < 0.05) in a concentration of 1 μmol·L −1 . (f) The α3β2 antagonist α‐conotoxin PnIA (C. PnIA) did not influence the nicotine effect (ΔI SC ) in a concentration of 100 nmol·L −1 ( n = 6; ns, not significant) but significantly reduced the nicotine‐induced current in a concentration of 500 mmol·L −1 (ΔI SC , n = 5, * P < 0.05)
    α Conotoxin Imi, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/α conotoxin imi/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    α conotoxin imi - by Bioz Stars, 2023-09
    93/100 stars

    Images

    1) Product Images from "Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors"

    Article Title: Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors

    Journal: British Journal of Pharmacology

    doi: 10.1111/bph.15270

    Effect of nicotinic receptor agonists and antagonists on transepithelial ion transport of mouse tracheal epithelium. (a) The α7 nicotinic ACh receptor (nAChR) antagonist α‐bungarotoxin (αBTX, 100 nmol·L −1 , n = 5, apical) or the α7 nAChR antagonist α‐conotoxin ImI (C. ImI, 4 μmol·L −1 , apical) or the α9α10 nAChR antagonist ACV‐1 (100 nmol·L −1 , apical) did not influence the nicotine effect (100 μmol·L −1 , apical, ΔI SC ; ns, not significant). (b) The epibatidine‐induced (α4β2, α3β2, α4β4 and α3β4 nAChR agonist) current peak (1 μmol·L −1 ) was significant compared to baseline current ( n = 5, * P < 0.05). Application of the α4β2 and α3β4 nAChR agonist A‐85380 (100 μmol·L −1 , apical, n = 5) significantly increased I SC (* P < 0.05). (c) The epibatidine effect was dose dependent ( n = 5 for each concentration). (d) In the presence of 1 μmol·L −1 of the α4β2, α3β2, α4β4 and α3β4 nAChR antagonist dihydro‐β‐erythroidine (DhβE), the nicotine effect (ΔI SC ) was similar to control conditions ( n = 5; ns, not significant), but 10 μmol·L −1 DhβE significantly reduced the nicotine‐induced current (ΔI SC , n = 5, * P < 0.05). (e) The α3β2 nAChR antagonist α‐conotoxin MII (C. MII) did not influence the nicotine effect (ΔI SC ) in a concentration of 50 nmol·L −1 ( n = 5; ns, not significant) but significantly reduced the nicotine‐induced current (ΔI SC , n = 5, * P < 0.05) in a concentration of 1 μmol·L −1 . (f) The α3β2 antagonist α‐conotoxin PnIA (C. PnIA) did not influence the nicotine effect (ΔI SC ) in a concentration of 100 nmol·L −1 ( n = 6; ns, not significant) but significantly reduced the nicotine‐induced current in a concentration of 500 mmol·L −1 (ΔI SC , n = 5, * P < 0.05)
    Figure Legend Snippet: Effect of nicotinic receptor agonists and antagonists on transepithelial ion transport of mouse tracheal epithelium. (a) The α7 nicotinic ACh receptor (nAChR) antagonist α‐bungarotoxin (αBTX, 100 nmol·L −1 , n = 5, apical) or the α7 nAChR antagonist α‐conotoxin ImI (C. ImI, 4 μmol·L −1 , apical) or the α9α10 nAChR antagonist ACV‐1 (100 nmol·L −1 , apical) did not influence the nicotine effect (100 μmol·L −1 , apical, ΔI SC ; ns, not significant). (b) The epibatidine‐induced (α4β2, α3β2, α4β4 and α3β4 nAChR agonist) current peak (1 μmol·L −1 ) was significant compared to baseline current ( n = 5, * P < 0.05). Application of the α4β2 and α3β4 nAChR agonist A‐85380 (100 μmol·L −1 , apical, n = 5) significantly increased I SC (* P < 0.05). (c) The epibatidine effect was dose dependent ( n = 5 for each concentration). (d) In the presence of 1 μmol·L −1 of the α4β2, α3β2, α4β4 and α3β4 nAChR antagonist dihydro‐β‐erythroidine (DhβE), the nicotine effect (ΔI SC ) was similar to control conditions ( n = 5; ns, not significant), but 10 μmol·L −1 DhβE significantly reduced the nicotine‐induced current (ΔI SC , n = 5, * P < 0.05). (e) The α3β2 nAChR antagonist α‐conotoxin MII (C. MII) did not influence the nicotine effect (ΔI SC ) in a concentration of 50 nmol·L −1 ( n = 5; ns, not significant) but significantly reduced the nicotine‐induced current (ΔI SC , n = 5, * P < 0.05) in a concentration of 1 μmol·L −1 . (f) The α3β2 antagonist α‐conotoxin PnIA (C. PnIA) did not influence the nicotine effect (ΔI SC ) in a concentration of 100 nmol·L −1 ( n = 6; ns, not significant) but significantly reduced the nicotine‐induced current in a concentration of 500 mmol·L −1 (ΔI SC , n = 5, * P < 0.05)

    Techniques Used: Concentration Assay

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • α conotoxin imi  (Alomone Labs)
    93
    Alomone Labs α conotoxin imi
    α Conotoxin Imi, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/α conotoxin imi/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    α conotoxin imi - by Bioz Stars, 2023-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results